Attitudes and practices towards HAART among people living with HIV/AIDS in a resource-limited setting in northern Burkina Faso

Public Health

Volumn 125, Issue 11, 2011, Pages 784-790

  Guiro, A K ^a   Traore, A ^b   Somda, A ^c   Huang, S L ^d  

^a Ouahigouya Hospital   (Burkina Faso)

^b AMMIE ^*  (Burkina Faso)

^c MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adherence; Attitude; Highly active antiretroviral treatment; Resource limited setting

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATTITUDINAL SURVEY; DISEASE TREATMENT; HEALTH CARE; HEALTH EDUCATION; HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS; PERCEPTION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTITUDE TO HEALTH; CONDOM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATION; FAMILY; FEMALE; FUNCTIONAL STATUS; HEALTH BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOME; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SELF DISCLOSURE; SELF REPORT; SEXUALITY; SOCIAL SUPPORT; STRUCTURED QUESTIONNAIRE; TAIWAN; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BURKINA FASO; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DISCLOSURE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIAL CLASS;

BURKINA FASO;

EID: 81255136141     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2011.09.015     Document Type: Article

References (21)

1. UNAIDS. Report on the global HIV/AIDS epidemic 2008. UNAIDS/08.25E/JC1510E. WHO Library Cataloguing-in-Publication Data; 2008.
2. UNGASS report 2008, Ministry of Health, Burkina Faso.
3. Chesney M.A. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000, 30(Suppl. 2):S171-S176.
4. Soria A., Porten K., Fampou-Toundji J.C., Galli L., Mougnutou R., Buard V., et al. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients. Antivir Ther 2009, 14:339-347.
5. Jallow S., Alabi A., Sarge-Njie R., Peterson K., Whittle H., Corrah T., et al. Virological response to highly active antiretroviral therapy (HAART) in HIV-2 and HIV-1/HIV-2 dually infected patients in The Gambia and the emergence of drug resistant variants. J Clin Microbiol 2009.
6. Hosseinipour M.C., van Oosterhout J.J., Weigel R., Phiri S., Kamwendo D., Parkin N., et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS 2009, 23:1127-1134.
7. Hanson D.L., Adje-Toure C., Talla-Nzussouo N., Eby P., Borget M.Y., Kouadio L.Y., et al. HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Cote d'Ivoire. AIDS Res Hum Retroviruses 2009, 25:489-495.
8. Meya D., Spacek L.A., Tibenderana H., John L., Namugga I., Magero S., et al. Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc 2009, 12:3.
9. Fumaz C.R., Munoz-Moreno J.A., Molto J., Ferrer M.J., Lopez-Blazquez R., Negredo E., et al. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs. AIDS Care 2008, 20:796-805.
10. Laurent C., Ngom Gueye N.F., Ndour C.T., Gueye P.M., Diouf M., Diakhate N., et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr 2005, 38:14-17.
11. Kouanfack C., Laurent C., Peytavin G., Ciaffi L., Ngolle M., Nkene Y.M., et al. Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in Cameroon. J Acquir Immune Defic Syndr 2008, 48:216-219.
12. Bell D.J., Kapitao Y., Sikwese R., van Oosterhout J.J., Lalloo D.G. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr 2007, 45:560-563.
13. Abaasa A.M., Todd J., Ekoru K., Kalyango J.N., Levin J., Odeke E., et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res 2008, 8:241.
14. Carlucci J.G., Kamanga A., Sheneberger R., Shepherd B.E., Jenkins C.A., Spurrier J., et al. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr 2008, 47:615-622.
15. UNAIDS. AIDS epidemic update: December 2007. UNAIDS/07.27E/JC1322E. WHO Library Cataloguing-in-Publication Data; 2007.
16. Bila B., Egrot M. Gender asymmetry in healthcare-facility attendance of people living with HIV/AIDS in Burkina Faso. Soc Sci Med 2009, 69:854-861.
17. Burkina Faso 2006 Census of general population and habitation 2006, Burkina Faso, Ouagadoougou.
18. Ware N.C., Idoko J., Kaaya S., Biraro I.A., Wyatt M.A., Agbaji O., et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 2009, 6:e11.
19. Halkitis P., Palamar J., Mukherjee P. Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS Patient Care STDS 2008, 22:323-335.
20. Binagwaho A., Ratnayake N. The role of social capital in successful adherence to antiretroviral therapy in Africa. PLoS Med 2009, 6:e18.
21. de Walque D., Kline R. Comparing condom use with different types of partners: evidence from national HIV surveys in Africa 2009, World Bank.